Sasken Comm in focus after fixing record date for buyback

Sasken Communication Technologies announced that it has fixed 6 January 2017 as record date for the proposed buyback of shares. The announcement was made after market hours yesterday, 26 December 2016. The company on Saturday, 24 December 2016 announced to the stock exchanges that the buyback committee of the board of directors, at its meeting held on 23 December 2016, fixed the buyback price of Rs 410 per share and the total consideration for buyback at Rs 120.04 crore excluding the transaction costs. This represents 16.52% of the total issued and paid-up equity share capital of the company as on 31 March 2016.

Capital First announced that the meeting of the debenture committee of the board of directors of the company will be held on 29 December 2016, to consider the private placement of rated, listed, secured/unsecured/perpetual, redeemable, non‐convertible securities in the nature of debentures. The debentures shall be listed on the debt market segment of National Stock Exchange of India (NSE). The announcement was made after market hours yesterday, 26 December 2016.

Shilpa Medicare announced that the board of directors, at its meeting held yesterday, 26 December 2016, allotted 30.25 lakh equity shares at Rs 570 per share in the name of TA FII Investors, Mauritius pursuant to the resolution passed by the shareholders at their extra-ordinary general meeting held on 26 December 2016 and in-principal approvals received from BSE and NSE. The announcement was made after market hours yesterday, 26 December 2016.

Apollo Hospitals Enterprise announced that the company has issued a letter of comfort for an aggregate sum of Rs 37.10 crore to ICICI Bank in connection with the sanction of credit facilities in favour of its step-down subsidiary, Alliance Dental Care Limited, Chennai. The announcement was made after market hours yesterday, 26 December 2016.

Kaya announced that the company is in receipt of letter dated 25 December 2016 issued by Kaya Middle East DMCC (Kaya DMCC) confirming the settlement of consideration amount for acquiring 75% beneficial interest in Minal Medical Centre, Dubai and Minal Specialized Clinic Dermatology, Sharjah. Hence, the corporate guarantee provided by the company stands cancelled on payment of the consideration amount by Kaya DMCC

On 27 September 2016, the company had announced the corporate guarantee provided by it on behalf of Kaya DMCC, wholly owned subsidiary of the company, for payment of AED 22.5 million by Kaya DMCC for acquiring 75% beneficial interest in Minal Medical Centre, Dubai and Minal Specialized Clinic Dermatology, Sharjah.

Powered by Capital Market - Live News